Sustanon Side Effects

Common Sustanon Side Effects

The most commonly reported Sustanon side effects (click to view or check a box to report):

Death (2)
Pituitary Tumour Benign (1)
Pituitary Tumour Recurrent (1)
Pain In Extremity (1)
Hypersensitivity (1)
Arterial Thrombosis Limb (1)
Cerebral Venous Thrombosis (1)

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Sustanon Side Effects Reported to FDA

The following Sustanon reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Sustanon on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Cerebral Venous Thrombosis
This is a report of a 27-year-old male patient (weight: NA) from FR, suffering from the following symptoms/conditions: NA, who was treated with Sustanon 250 (dosage: Unk, start time: Jul 05, 2013), combined with:
  • Nandrolone Decanoate (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Cerebral Venous Thrombosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Sustanon 250 treatment in male patients, resulting in cerebral venous thrombosis side effect. The patient was hospitalized.

Pituitary Tumour Recurrent
This report suggests a potential Sustanon /net/ Pituitary Tumour Recurrent side effect(s) that can have serious consequences. A 71-year-old male patient (weight: NA) from UNITED KINGDOM was diagnosed with the following symptoms/conditions: NA and used Sustanon /net/ (dosage: NA) starting NS. Soon after starting Sustanon /net/ the patient began experiencing various side effects, including:
  • Pituitary Tumour Recurrent
Drugs used concurrently:
  • Hydrocortisone
  • Atenolol
  • Bendroflumethiazide
  • Levothyroxine Sodium
  • Nifedipine
  • Somatropin Rdna (0.4 Mg, Unk)
Although Sustanon /net/ demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pituitary tumour recurrent, may still occur.

Pituitary Tumour Benign
This Pituitary Tumour Benign problem was reported by a health professional from UNITED KINGDOM. A 62-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: luteinising hormone deficiency,follicle-stimulating hormone deficiency,hypogonadism,blood thyroid stimulating hormone decreased. On Oct 06, 2005 this consumer started treatment with Sustanon (dosage: 250 Mg, Unk). The following drugs were being taken at the same time: NA. When commencing Sustanon, the patient experienced the following unwanted symptoms/side effects:
  • Pituitary Tumour Benign
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pituitary tumour benign, may become evident only after a product is in use by the general population.

This is a report of a 80-year-old male patient (weight: NA) from UNITED KINGDOM. The patient developed the following symptoms/conditions: hypogonadism male,primary hypothyroidism,blood follicle stimulating hormone decreased,blood luteinising hormone decreased,blood thyroid stimulating hormone decreased and was treated with Sustanon (dosage: NA) starting Mar 17, 2000. Concurrently used drugs:
  • Levothyroxine
  • Nebido
  • Testosterone
  • Levothyroxine (150 Ug, 1x/day)
Soon after that, the consumer experienced the following side effects:
    This opens a possibility that Sustanon treatment could cause the above reactions, including death, and some male subjects may be more susceptible.

    A 82-year-old male patient (weight: NA) from UNITED KINGDOM with the following symptoms/conditions: hypogonadism male,luteinising hormone deficiency,blood follicle stimulating hormone decreased,blood corticotrophin abnormal,gastric disorder,growth hormone deficiency,hypothyroidism started Sustanon treatment (dosage: NA) on Sep 26, 2002. Soon after starting Sustanon treatment, the subject experienced various side effects, including:
      Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Sustanon.

      A 47-year-old male patient from UNITED KINGDOM (weight: NA) experienced symptoms, such as: NA and was treated with Sustanon 250(dosage: NA). The treatment was initiated on Nov 01, 2000. After that a consumer reported the following side effect(s):
      • Hypersensitivity
      Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Sustanon 250 efficacy:
      • Testosterone

      Arterial Thrombosis Limb, Pain In Extremity
      In this report, Sustanon (sustanon /00593501/) was administered for the following condition: klinefelter's syndrome.A 30-year-old male consumer from TURKEY (weight: NA) started Sustanon (sustanon /00593501/) treatment (dosage: 250 Vial, Injection) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
      • Arterial Thrombosis Limb
      • Pain In Extremity
      A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Sustanon (sustanon /00593501/) treatment could be related to the listed above side effect(s).

      Top 10 Sustanon Side Effects for Women

      Women Side EffectsReports

      Keep Track of Side Effects

      Note Your Observations

      It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

      Why Your Notes are Important

      Your notes could be helpful in several ways:

    • You can use them to remind you of details that may alert your health care professional(s) to a problem
    • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

    • Log Form

      You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

      Medicine Name and Dosage:
      Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
      Scale: 1 = very mild to 10 = very bad

      You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

      Discuss Sustanon Side Effects

      Did You Have a Sustanon Side Effect?

      Yes, Severe
      Yes, Moderate
      Yes, Minor

      How Effective is Sustanon for You?

      Exceeded Expectations
      Somewhat Effective
      Not Effective

      Sustanon Safety Alerts, Active Ingredients, Usage Information

      More About Sustanon

      Side Effects reported to FDA: 7

      Sustanon safety alerts: No

      Reported deaths: 2

      Reported hospitalizations: 1

      Latest Sustanon clinical trials